Gregory R. Ott
27Patents
6h-index
73Co-inventors
72Inventor score
Filing activity: Mar 16, 2001 → Apr 29, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6740649B2 | Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- &agr; converting enzyme (TACE) | Chemistry; Metallurgy | 15 | Expired |
| US8148391B2 | Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-Met inhibitors | Chemistry; Metallurgy | 11 | Active |
| US9604994B2 | Thienopyrimidine inhibitors of atypical protein kinase C | Chemistry; Metallurgy | 11 | Active |
| US6984648B2 | Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α | Chemistry; Metallurgy | 10 | Expired |
| US6743807B2 | Cyclic &bgr;-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-&agr; | Chemistry; Metallurgy | 10 | Expired |
| US8552186B2 | Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitors | Chemistry; Metallurgy | 9 | Active |
| US9132128B2 | Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor | Chemistry; Metallurgy | 4 | Active |
| US9339502B2 | Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor | Chemistry; Metallurgy | 3 | Active |
| US9914730B2 | Azaquinazoline inhibitors of Atypical protein Kinase C | Chemistry; Metallurgy | 3 | Active |
| US9896446B2 | Azaquinazoline inhibitors of atypical protein kinase C | Chemistry; Metallurgy | 2 | Active |
| US9623026B2 | Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor | Chemistry; Metallurgy | 2 | Active |
| US11020396B2 | Pyrimidinone derivatives as Cdc7 inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10111872B2 | Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor | Chemistry; Metallurgy | 1 | Active |
| US8471005B2 | Pyrrolotriazines as ALK and JAK2 inhibitors | Human Necessities | 1 | Active |
| US9487529B2 | Macrocyclic compounds as ALK, FAK and JAK2 inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10632119B2 | Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor | Chemistry; Metallurgy | 0 | Active |
| US9238656B2 | Imidazo[4,5-b]pyridine derivatives as ALK and JAK modulators for the treatment of proliferative disorders | Chemistry; Metallurgy | 0 | Active |
| US12227521B2 | CGRP antagonist compounds | Chemistry; Metallurgy | 0 | Active |
| US9440984B2 | Pyrrolotriazines as ALK inhibitors | Human Necessities | 0 | Active |
| US10919896B2 | Preparation and uses of pyrimidinone derivatives | Chemistry; Metallurgy | 0 | Active |
| US6720329B2 | Spiro-cyclic &bgr;-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-&agr; converting enzyme (TACE) | Chemistry; Metallurgy | 0 | Expired |
| US6962938B2 | Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE) | Chemistry; Metallurgy | 0 | Expired |
| US10954251B2 | Thienopyrimidine inhibitors of atypical protein kinase C | Chemistry; Metallurgy | 0 | Active |
| US11766434B2 | Pyrimidinone derivatives as CDC7 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US12344621B2 | CGRP antagonist compounds | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.